Citi Starts AmSurg (AMSG) at Buy
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Citi initiated coverage on AmSurg (NASDAQ: AMSG) with a Buy rating.
Shares of AmSurg closed at $64.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Starts Calithera Biosciences (CALA) at Sell
- Imperial Capital Raises Price Target on Spirit Airlines (SAVE); Cuts 4Q Estimates
- Wedbush Raises price Target on NCR Corp. (NCR) Following 3Q; Reiterates Neutral
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!